(13)The active substances in the Union list should be regularly examined to take account of developments in science and technology. Where there are significant indications that an active substance used in biocidal products or treated articles does not meet the requirements of this Regulation, the Commission should be able to review the approval of the active substance.
◷
New version applies from 23/09/2013.
165 provisions change.
Later versions: 25/04/2014, 20/11/2019, 29/03/2021, 10/06/2021, 15/04/2022, 26/05/2024, 11/06/2024, 15/06/2026, 19/08/2026.
Recital 13 changes in this version: compare with the current text.